BD (NYSE: BDX) shares ticked up before hours today on third-quarter results that came in ahead of the consensus Wall Street ...

Medical technology company Becton, Dickinson and Company (NYSE:BDX) met Wall Street’s revenue expectations in Q2 CY2025, with ...

The syringes are said to be produced using a hands-free and fully automated process to minimise contamination risks.

Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.68 in the third quarter of fiscal 2025, up 5.1% year over year. The figure topped the Zacks ...

The company said it has grown capacity by 10% this year, bringing its total U.S. output of the prefilled flush syringes to ...

The press release and presentation can be accessed on the IR website at investors.bd.com. Leading today's call are Tom Polen, BD's Chairman, Chief Executive Officer and President; and Chris DelOrefice ...

BD will invest $35M to expand its Nebraska syringe plant, adding 50 jobs and boosting U.S. supply of essential medical ...

The good doctor and a former familiar face at the detective desk in the Special Victims Unit are set to return to the beloved ...

Connecticut College researchers have found that chemical byproducts produced by the amphibian-killing fungus Batrachochytrium ...

As of 30 June 2025, total equity attributable to shareholders reached BD 43,141,313, a 1% decline from the BD 43,377,483 ...